Eagle Capital Select Equity ETF(EAGL.US)

Last Updated 19:00:00 ET
longbridge loading
Company Encyclopedia
View More
name
Eagle Capital Select Equity ETF
EAGL.US
News
View More

Sequoia will invest heavily, Anthropic's financing exceeds $25 billion, with a valuation of up to $350 billion

According to reports, Anthropic's current financing target is as high as $25 billion or even more, with GIC and Coatue each leading with $1.5 billion, and Microsoft and NVIDIA committing a total investment of $15 billion. The remaining funding gap of over $10 billion will be filled by venture capital firms and other investors, including Sequoia Capital. Sequoia Capital's significant investment in this OpenAI competitor marks a strategic shift in its AI track to "full coverage."

Wallstreetcn·
Wallstreetcn·

Is Danaher Corp Gaining or Losing Market Support?

Danaher Corp's short interest has decreased by 4.35%, with 8.29 million shares sold short, representing 1.32% of available shares. It would take an average of 3.19 days for traders to cover their short positions. A decline in short interest may indicate a more bullish market sentiment towards the stock. Compared to its peers, Danaher Corp has a lower short interest percentage of 7.36%.

benzinga_article·
US
DHR
-1.63%
benzinga_article·
US
DHR
-1.63%

Tema Etfs LLC Purchases New Stake in Capital One Financial Corporation $COF

Tema Etfs LLC has acquired a new stake in Capital One Financial Corporation (NYSE: COF), purchasing 10,114 shares valued at approximately $2.15 million, as reported in their recent 13F filing with the SEC. Other institutional investors have also adjusted their positions in the company. Analysts have set new price targets for COF, with Barclays raising its target from $271 to $294, and Citigroup increasing it from $290 to $310. Insider trading activity has seen significant sales, with insiders selling nearly 299,000 shares worth over $67 million in the last 90 days.

Market Beat·
US
COF
+0.92%
Market Beat·
US
COF
+0.92%

'Top Healthcare Pick for 2026,' Says Bernstein on UnitedHealth Stock (UNH). Here's Why

Bernstein analyst Lance Wilkes maintains an Outperform rating on UnitedHealth Group (UNH), despite a 36% decline over the past year. He sets a $444 price target, calling it his "top healthcare pick for 2026." Wilkes anticipates a recovery in the health insurance sector, with margins improving in Medicare Advantage and Medicaid. He highlights UnitedHealth's strategic moves to enhance profitability and its potential for earnings growth. The stock has a Strong Buy consensus on Wall Street, with an average price target of $397.82, suggesting an 18.95% upside.

Tip Ranks·
US
UNH
-2.34%
Tip Ranks·
US
UNH
-2.34%

CapitalOne Is Tumbling on Trump’s 10% Card Rate Cap Threat. Should You Buy COF Stock?

CapitalOne Is Tumbling on Trump’s 10% Card Rate Cap Threat. Should You Buy COF Stock?

Barchart Option·
US
COF
+0.92%
Barchart Option·
US
COF
+0.92%
© 2026 Longbridge｜Disclaimer